Go Pro
Eve Burstein

Eve Burstein Analyst Performance

Senior Analyst at Sanford C. Bernstein

Eve Burstein is a stock analyst at Sanford C. Bernstein in the medical sector, covering 8 publicly traded companies. Over the past year, Eve Burstein has issued 17 stock ratings, including strong buy, buy, and hold recommendations. While full access to Eve Burstein's proprietary MarketBeat Analyst Ranking is reserved for MarketBeat All Access subscribers, the rating is updated daily to reflect the most recent analyst activity. This profile highlights Eve Burstein's coverage history, rating activity, and performance tendencies — helping individual investors make more informed trading decisions.

Analyst Rankings, Coverage, and Performance Statistics

Average Return
00.00% 12-Month ROI
Success Rate
00.00% Profitable Ratings
Total Ratings
18 Last 1 Years
Buy Recommendations
55.56% 10 Buy Ratings
Companies Covered
8 Unique Companies

Ratings Distribution

RatingPercentageCount
Strong Buy22.2%4 ratings
Buy33.3%6 ratings
Hold44.4%8 ratings
Sell0.0%0 ratings

Out of 18 total stock ratings issued by Eve Burstein at Sanford C. Bernstein, the majority (44.4%) have been Hold recommendations, followed by 33.3% Buy and 22.2% Strong Buy.

Exchange Coverage

ExchangePercentageCount
NYSE
62.5% of companies on NYSE
5 companies
NASDAQ
37.5% of companies on NASDAQ
3 companies

Eve Burstein, an analyst at Sanford C. Bernstein, currently covers 8 companies listed on NYSE and NASDAQ, with the majority traded on NYSE.

Coverage Focus

Sector IconSectorPercentage
Medical
8 companies
100.0%

Eve Burstein of Sanford C. Bernstein specializes in stock coverage within the Medical sector.

Coverage Industries

IndustryPercentage
MEDICAL SERVICES
3 companies
37.5%
MED - BIOMED/GENE
2 companies
25.0%
MED INSTRUMENTS
2 companies
25.0%
MED PRODUCTS
1 company
12.5%

Eve Burstein's Ratings History at Sanford C. Bernstein

Recommendation ROI is the percentage between the price on the Report Date to the price 12 months after the report date.
Available with a MarketBeat All Access Subscription
12-Month ROIUpgrade to All Access to use the All ROI Filter
CompanyReport DateActionReport Date Price12-Month
Price Target
Rating12-Month
Price & ROI
Details
Guardant Health, Inc. stock logo
GH
Guardant Health
7/2/2026Boost Price Target$170.77$200.00Outperform
Illumina, Inc. stock logo
ILMN
Illumina
6/26/2026Initiated Coverage$177.65$185.00Market Perform
Revvity Inc. stock logo
RVTY
Revvity
6/26/2026Initiated Coverage$113.60$115.00Market Perform
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
6/26/2026Initiated Coverage$506.19$520.00Market Perform
Avantor, Inc. stock logo
AVTR
Avantor
6/26/2026Initiated Coverage$10.07$10.50Market Perform
Guardant Health, Inc. stock logo
GH
Guardant Health
6/26/2026Initiated Coverage$142.94$175.00Outperform
Natera, Inc. stock logo
NTRA
Natera
6/26/2026Initiated Coverage$260.75$310.00Outperform
Waters Corporation stock logo
WAT
Waters
6/26/2026Initiated Coverage$377.06$435.00Outperform
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
6/26/2026Initiated Coverage$135.73$155.00Outperform
Agilent Technologies, Inc. stock logo
A
Agilent Technologies
6/25/2026Upgrade$136.29Strong-Buy
Avantor, Inc. stock logo
AVTR
Avantor
6/25/2026Upgrade$10.30Hold
Guardant Health, Inc. stock logo
GH
Guardant Health
6/25/2026Upgrade$149.22Strong-Buy
Illumina, Inc. stock logo
ILMN
Illumina
6/25/2026Upgrade$176.55Hold
Natera, Inc. stock logo
NTRA
Natera
6/25/2026Upgrade$261.91Strong-Buy
Revvity Inc. stock logo
RVTY
Revvity
6/25/2026Upgrade$112.99Hold
Thermo Fisher Scientific Inc. stock logo
TMO
Thermo Fisher Scientific
6/25/2026Upgrade$513.54Hold
Waters Corporation stock logo
WAT
Waters
6/25/2026Upgrade$369.65Strong-Buy
Natera, Inc. stock logo
NTRA
Natera
1/10/2025Boost Price Target$173.64$200.00Outperform